Newcells Biotech Company
Preclinical solutions, iPS cells, 3D culture, regenerative medicine. Believe that combining the “best biology” into 3-D environments is the future of in vitro cell based assays that deliver superior data to support in vitro to in vivo translation.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
7-7
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
2
Total Funding:
£2.2M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership